EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival

The EMS1 and CCND1 genes at chromosome 11q13 are amplified in about 15% of primary breast cancers but appear to confer different phenotypes in ER positive and ER negative tumours. Since there are no published data on EMS1 expression in large series of breast cancers we examined the relationship of EMS1 expression with EMS1 gene copy number and expression of mRNAs for cyclin D1 and ER. In a subset of 129 patients, where matched tumour RNA and DNA was available, EMS1 mRNA overexpression was associated predominantly with gene amplification (P = 0.0061), whereas cyclin D1 mRNA overexpression was not (P = 0.3142). In a more extensive series of 351 breast cancers, there was no correlation between cyclin D1 and EMS1 expression in the EMS1 and cyclin D1 overexpressors (P = 0.3503). Although an association between EMS1 mRNA expression and ER positivity was evident (P = 0.0232), when the samples were divided into quartiles of EMS1 or cyclin D1 mRNA expression, the increase in the proportion of ER positive tumours in the ascending EMS1 mRNA quartiles was not statistically significant (P = 0.0951). In marked contrast there was a significant stepwise increase in ER positivity in ascending quartiles of cyclin D1 mRNA (P = 0.030). A potential explanation for this difference was provided by the observation that in ER positive breast cancer cells oestradiol treatment resulted in increased cyclin D1 gene expression but was without effect on EMS1. The relationship between EMS1 expression and clinical outcome was examined in a subset of 234 patients with median follow-up of 74 months. High EMS1 expression was associated with age > 50 years (P = 0.0001), postmenopausal status (P = 0.0008), lymph node negativity (P = 0.019) and an apparent trend for worse prognosis in the ER negative subgroup. These data demonstrate that overexpression of EMS1 mRNA is largely due to EMS1 gene amplification, is independent of cyclin D1 and ER expression and, in contrast to cyclin D1, is not regulated by oestrogen. Independent overexpression of these genes may confer different phenotypes and disease outcomes in breast cancer as has been inferred from recent studies of EMS1 and CCND1 gene amplification.     

Toxicity of nitro compounds fromLotus pedunculatus to grass grub (Costelytra zealandica) (Coleoptera: Scarabaeidae)

Crude extracts of root of the forage legumesLotus pedunculatus andCoronilla varia (crownvetch) were toxic when administered orally to 3rd instarCostelytra zealandica larvae. A group of 3-nitropropanoyl-d-glucopyranoses was isolated from active fractions of the crude extracts. These toxins, some of which were already known fromC. varia, have not previously been reported fromL. pedunculatus. The compounds were present in root tissue of this species at a concentration of about 1% dry weight. They include the triester karakin and the diesters coronarian and cibarian, all of which were toxic to larvae ofC. zealandica at levels which could account fully for the activity of the crude extracts.     

Note on the movement of insecticide droplets through and out of a crop canopy after emission below canopy level

Coarse aerosol sprays with number median diameters in the range 30–40 μm were emitted at 0.25 m above the ground within the canopy of a cotton crop planted at 0.93 m row separation and standing 1.0 m tall. Movement of spray was monitored by vertical stepped paper tower samplers with narrowest section of width 0.13 cm, giving collection by inertial impaction down to 10 μm in a 1 m/sec wind. Horizontal paper targets were used to sample droplets depositing by sedimentation. Droplet number counts indicated that under conditions of moderate instability and associated convective turbulence, droplets were drawn rapidly out of the crop to a height of 2 m (the upper level sampled). The peak concentration of the spray cloud was centred at a height of between 1.0 and 2.0 m beyond 1.0 m downwind of the emission point in the first test, using droplet spectrum with volume median diameter of 41 μm, and beyond 2.5 m downwind of the emission point in the second test with spectrum of 57 μm volume median diameter. Inertial impaction at the 0.25 and 0.5 m levels was slight, except on the samplers within 0.5 m of the sprayer, and sedimentation was only significant at and below 0.5 m in the first two rows sampled. The moderate wind speed of 2.5 m/sec at canopy level produced marked inertial impaction over the first 4.5 m downwind of the sprayer at the 1.0 m level.     

Value recovery from end-of-use products facilitated by automated dismantling planning

Circular economy is a promising business model that promotes sustainable development by closing material loops. Making progress toward a circular economy requires the recovery of valuable materials and components from end-of-use products and subsequent reuse of them in some form, thus maximizing the utility of components and materials. Currently, end-of-use products value recovery is carried out without a rational planning, causing the loss of the recoverable value embedded in material and components. To address this problem, dismantling planning and appropriate technologies should be employed to improve the economic performance of end-of-use products value recovery. In this paper, a two-stage dismantling planning method is proposed to find a profitable end-of-use strategy. In the first stage of this method, disassembly optimization model is constructed and can be executed to obtain the optimal disassembly plan allowing maximum preservation of component function value, in a preservative disassembly scenario. To speed up the modeling, a method for automatic generation of AND/OR graph—a structure of incorporating all possible disassembly operations and associated subassemblies, is presented. In the second stage of the method, in order to increase profitability, Pareto analysis is employed to identify bottlenecks to disassembly and automated/destructive technologies are considered to remove the bottlenecks. A hard disk drive serves as a case study to illustrate the suggested method.     

The clinical assessment of cancer tests: a statistical approach to the prediction of "false positive" rates from controls

As the sensitivity of the new in vitro cancer detection techniques increases, a larger number of "false positive" results can be expected from control populations apparently free from malignant disease at the time of the test. An attempt is made to predict the number of unexplained positives, together with the expected age and sex distribution, using published cancer registration statistics. The predicted numbers are compared with the observed numbers of unexplained positives in two clinical trials of the MEM test.